(Q44658917)

5 December 2017

title

Effect of the new thiazolidinedione-pioglitazone on the development of oxidative stress in liver and kidney of diabetic rabbits (English)

1 reference

5 December 2017

1

Anna Gumieniczek

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

5 December 2017

19 December 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14623026

full work available at URL

3 April 2024

https://api.elsevier.com/content/article/PII:S0024320503008804?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

https://api.elsevier.com/content/article/PII:S0024320503008804?httpAccept=text/plain

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

3 April 2024

1 reference

5 December 2017

volume

74

1 reference

5 December 2017

issue

5

1 reference

5 December 2017

page(s)

553-562

1 reference

5 December 2017

1

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus

3 April 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

Ascorbate metabolism and its regulation in animals

3 April 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and atherosclerosis

3 April 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

Amelioration of alloxan induced diabetes mellitus and oxidative stress in rats by oil of Eruca sativa seeds

3 April 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

Dietary troglitazone decreases oxidative stress in early stage type II diabetic rats

3 April 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus

3 April 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

Antioxidant enzyme activities and malondialdehyde levels related to aging

3 April 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells

3 April 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

High glucose concentrations abolish the superoxide dismutase response of leukocytes to ascorbic acid or troglitazone in type 2 diabetes mellitus

3 April 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

Antioxidant defense system in diabetic kidney: a time course study

3 April 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes

3 April 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

Impaired reductive regeneration of ascorbic acid in the Goto-Kakizaki diabetic rat.

3 April 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

A simple colorimetric method for ascorbic acid determination in blood plasma

3 April 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

Tissue ascorbic acid and polyol pathway metabolism in experimental diabetes

3 April 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

Protein measurement with the Folin phenol reagent

3 April 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

Novel phthalazinone and benzoxazinone containing thiazolidinediones as antidiabetic and hypolipidemic agents

3 April 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

Further prove on oxidative stress in alloxan diabetic rat tissues

3 April 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

PPARgamma agonists for intestinal ischaemia

3 April 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

Antioxidant status and lipid peroxidation in human feto-placental unit

3 April 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation

3 April 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

Renal cortical expression of mRNAs for antioxidant enzymes in normal and diabetic rats

3 April 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

Change in tissue concentrations of lipid hydroperoxides, vitamin C and vitamin E in rats with streptozotocin-induced diabetes.

3 April 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

Effect of insulin on impaired antioxidant activities in aortic endothelial cells from diabetic rabbits

3 April 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

Antioxidant status in experimental type 2 diabetes mellitus: effects of glibenclamide and glipizide on various rat tissues

3 April 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2003.03.004

3 April 2024

Identifiers

1 reference

5 December 2017

1 reference